SEC Form 4 · accession 0001645627-17-000099
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 21, 2017
Accepted (ET)
Jul 24, 2017 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.0214 | A | 21,971,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.0214 | A | 21,973,389 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.02 | A | 21,978,389 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.0212 | A | 21,983,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.0207 | A | 21,985,389 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.0207 | A | 21,990,389 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.0227 | A | 21,995,389 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $0.0228 | A | 22,000,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.0228 | A | 22,002,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.023 | A | 22,004,389 | D |
Table II — derivative securities
No Table II lines on this filing.